These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 8334526)
61. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Done CJ; Sharp T Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575 [TBL] [Abstract][Full Text] [Related]
62. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon. Kleven MS; Koek W J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301 [TBL] [Abstract][Full Text] [Related]
63. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture. Riad M; Emerit MB; Hamon M Brain Res Dev Brain Res; 1994 Oct; 82(1-2):245-58. PubMed ID: 7842512 [TBL] [Abstract][Full Text] [Related]
64. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride. Ryan CN; Evenden JL; Petterson M Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008 [TBL] [Abstract][Full Text] [Related]
65. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats. Krebs KM; Geyer MA Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855 [TBL] [Abstract][Full Text] [Related]
66. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task. Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031 [TBL] [Abstract][Full Text] [Related]
67. Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. Gartside SE; Ellis PM; Sharp T; Cowen PJ Eur J Pharmacol; 1992 Oct; 221(1):27-33. PubMed ID: 1333974 [TBL] [Abstract][Full Text] [Related]
68. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat. Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015 [TBL] [Abstract][Full Text] [Related]
69. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta. Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536 [TBL] [Abstract][Full Text] [Related]
70. Cardiovascular responses produced by microinjection of serotonin-receptor agonists into the paraventricular nucleus in conscious rats. Bell AA; Butz BL; Alper RH J Cardiovasc Pharmacol; 1999 Feb; 33(2):175-80. PubMed ID: 10028923 [TBL] [Abstract][Full Text] [Related]
72. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172 [TBL] [Abstract][Full Text] [Related]
73. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Pan L; Gilbert F Neuroendocrinology; 1992 Dec; 56(6):797-802. PubMed ID: 1369587 [TBL] [Abstract][Full Text] [Related]
74. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse. Dursun SM; Handley SL Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640 [TBL] [Abstract][Full Text] [Related]
75. Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat. Baudrie V; De Vry J; Broqua P; Schmidt B; Chaouloff F; Glaser T Eur J Pharmacol; 1993 Feb; 231(3):395-406. PubMed ID: 8095465 [TBL] [Abstract][Full Text] [Related]
76. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Gilbert F; Brazell C; Tricklebank MD; Stahl SM Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920 [TBL] [Abstract][Full Text] [Related]
77. Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release. Kommalage M; Höglund AU Eur J Pharmacol; 2005 Feb; 509(2-3):127-34. PubMed ID: 15733547 [TBL] [Abstract][Full Text] [Related]
78. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins. Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559 [TBL] [Abstract][Full Text] [Related]
80. Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Done CJ; Sharp T Neuropharmacology; 1994; 33(3-4):411-21. PubMed ID: 7984279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]